We reported recently that weight cycling significantly increased the incidence of mammary cancer in virgin female rats that were pretreated with N-methyl-N-nitrosourea. The present study investigated the effect of weight cycling on mammary epithelial cell proliferation and its relationship to changes in plasma insulin, estrogen, progesterone and urinary corticosterone in 30 female virgin Sprague-Dawley rats. Animals were fed a modified AIN-76A diet containing 24.6% corn oil by weight. Weight-cycled (WC) rats were food restricted daily by either 33% or 50% of non-restricted controls for 1 week followed by 3 weeks compensatory refeeding and weight recovery over 18 weeks or 4.5 weight cycles. WC rats consumed 6-10% less food than controls (P ⍧ 0.01) but showed a 71-89% greater efficiency of food utilization for growth (P < 0.0001) than controls. There were no differences in total weight gain during treatment. Mammary lobuloalveolar and ductal cell proliferation of WC rats, measured by 5-bromo-2Јdeoxyuridine labelling, increased in a dose-response fashion, P ⍧ 0.03, P ⍧ 0.06 respectively in comparison to controls. Energy and substrate utilization measured by indirect calorimetry indicated WC animals expended less energy (P ⍧ 0.005) and utilized less glucose (P ⍧ 0.0001) and protein (P ⍧ 0.006) during restriction, and less lipid during recovery (P ⍧ 0.05) than controls. There were no significant differences in hormone levels between groups. Multiple regression analysis with plasma insulin, estrogen, progesterone and urinary corticosterone as independent variables (r ⍧ 0.947, r 2 ⍧ 0.897, P ⍧ 0.003) showed that plasma insulin was the only significant predictor (P < 0.01) of mammary cell proliferation. In accord with this observation, tyrosinephosphorylated activation of insulin receptor substrate-1, detected by immunoprecipitation and Western immunoblot analysis in mammary tumors of WC rats from our previous study, was 3-5 times greater than in non-restricted controls (P < 0.01). Present findings suggest that weight cycling in rats increases risk of breast cancer development via insulin stimulated mammary cell proliferation. *Abbreviations: MNU, N-methyl-N-nitrosourea; IRS-1, insulin receptor substrate-1; BRDU, 5-bromo-2Ј-deoxyuridine; DMBA, 7, anthracene; EGF, epidermal growth factor.
Introduction
We reported recently that weight cycling abolished the protective effects of chronic restriction against mammary carcinogenesis (1) . Rats that were administered N-methyl-Nnitrosourea (MNU*) and food restricted by 33% for 1 week, and then refed for 3 weeks (i.e. weight cycled) repeatedly for 18 weeks, consumed significantly less food, but showed a greater incidence of breast cancer than ad libitum-fed animals. Although body weight gain of the weight-cycled animals was less than the ad libitum animals, their efficiency for growth (i.e. total weight gain/total food intake ϫ100) was consistently greater. Measurement of substrate utilization by indirect calorimetry indicated that the weight-cycled animals used more glucose and less fatty acid for energy than the non-restricted animals during their recovery from food restriction.
Several hormones have been associated with mammary cell proliferation (2) . In particular, insulin is both a regulator of energy metabolism and a mitogenic stimulus of peripheral tissue growth. It has been shown to be essential for mammary gland development (3) and a promoter of mammary tumorigenesis in laboratory rats (4) (5) (6) . Similarly, mammary gland growth (7) and tumorigenesis are directly affected by circulating ovarian sex hormones (8) . On the other hand, corticosterone, a counter-regulatory hormone of insulin, has been reported to inhibit mammary cancer development (9) .
Therefore, the loss of protection against mammary cancer that we observed in response to weight cycling could be related either to an increased stimulation of mammary cell proliferation by insulin and estrogen and/or an inhibition of adrenal corticosteroid function.
In the present study, the effects of weight cycling on mammary epithelial cell proliferation were examined in relation to plasma concentration of insulin, estrogen, progesterone and urinary corticosterone. Related to that experiment, we also measured tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), a cytoplasmic marker of insulin stimulation, in tumor tissue of weight-cycled and control animals from our previous study (1) . Also, in the present experiment, the effects of weight cycling were studied using two levels of food restriction and a regimen of ad libitum and meal feeding. The rationale for including these additional treatment conditions was to determine whether the physiological effect of weight cycling on mammary tissue may vary with feeding regimen and intensity of food restriction.
We report herein, that weight cycling stimulated mammary lobuloalveolar cell proliferation in a dose-response fashion. Furthermore, the increase in mammary cell proliferation could be explained primarily by circulating levels of plasma insulin. Phosphorylated IRS-1 levels in mammary tumors of weightcycled animals were several fold greater than in tumors of non-restricted control animals. Estrogen, progesterone and corticosterone were not found to be major predictors of mammary cell proliferation.
Materials and methods

Experiment 1
Thirty 28-day-old virgin female Sprague-Dawley rats were obtained from Taconic Farms (Germantown, NY). The animals were housed individually in suspended stainless steel cages equipped with tunnel feeders. The animal room was maintained at 25°C and 50 Ϯ 2% humidity under a 12 h reverse light-dark cycle (0800-2000 h dark, 2000-0800 h light). For 3 weeks following their arrival, the animals were adapted to eating in two 3 h meal sessions (0800-1100 h and 1700-2000 h) on a reverse 12 h light-dark cycle. During the same period the animals were adapted to the metabolic testing chambers. Animals were fed the same modified AIN-76A diet containing 50 g/kg corn oil as reported previously (1) . At 50 days old, the animals were assigned randomly and evenly to one of five treatment groups: group 1, ad libitum control (Ad lib-C); group 2, meal eater control (ME-C); group 3, ad libitum-fed and 33% food restricted (Ad lib-WC 33 ); group 4, meal fed and 33% food restricted (ME-WC 33 ); and group 5, meal fed and 50% food restricted (ME-WC 50 ). Experimental animals were food restricted by either 33% or 50% of the Ad lib-C intake for 1 week followed by 3 weeks refeeding. During the 3 weeks of refeeding, the animals were fed daily the same volume of food as consumed by group 1 plus a fraction of the food volume that was restricted, so that at the end of a 4 week period, or weight cycle, the restricted animals were fed the same quantity of food as consumed by Ad lib-C. Animals in the ME-WC and ME-C groups were fed their food allotment in two 3 h meals; weight cycled and control groups, fed ad libitum, were given free access to their food allotment. Also at that time, animals were fed a modified AIN-76A diet containing 246 g/kg fat (corn oil). After 3 days, the experimental treatment started and continued for 4.5 weight cycles or 18 weeks. Food intake was measured daily and body weight, weekly. Also, efficiency of food utilization for growth (total weight gain/total food intakeϫ100) was calculated during weeks of food restriction and refeeding. Estrous cyclicity was monitored during the first, third and fifth weight cycles.
Energy and substrate utilization were measured by indirect calorimetry using an open circuit pass-through system. Substrate utilization in this study, actually represented rate of disappearance of substrates (i.e. glucose, lipid, and protein) in metabolism. Depending upon the nutritional state of the animal, the disappearance rate could mean the rate of oxidation of the substrate for energy or its interconversion to another intermediate that could be oxidized or stored for energy. For example, an increase in glucose utilization (i.e. disappearance) during recovery from restriction would reflect both oxidation of glucose for energy and glucose conversion to glycerol for triglyceride storage in adipose tissue. Also, a decrease in urinary nitrogen excretion in response to restriction would indicate a recycling of nitrogen for protein metabolism and an increased interconversion of carbon units to glucose via gluconeogenesis. Under normal free feeding conditions, circulating glucose is used more readily than lipids for energy, but that difference in utilization becomes smaller during conditions of food restriction when more lipids and less glucose are utilized. In the study, resting metabolic rate of 25 animals (five animals/group) was measured for one food restriction and one recovery day during each of the first four weight cycles. For the first weight cycle, metabolic testing was done for 24 h during food restriction and each of the 3 weeks of refeeding. During subsequent weight cycles, metabolic testing was done for 24 h during the food restriction week and during one of the 3 weeks of refeeding. Rates of oxygen consumption and carbon dioxide production were sampled for 3 min every 16 min from five individual chambers equipped with food cups and water. Concentrations of oxygen and carbon dioxide were corrected automatically to standard temperature and pressure by mass flow controller (Sierra Instruments, Monterey, CA) and analyzed by a pair of gas analyzers (Ametek, Pittsburgh, PA). Sampling of gases and calculation of energy and substrate utilization were done on line utilizing a computer equipped with a software program using the equations reported by Simonson and DeFronzo (10) . Rates of total energy expended and energy from glucose and fatty acids were determined using non-protein respiratory quotient. The rate of protein oxidation was determined by measuring 24 h urinary nitrogen.
During week 18 of the experiment, each animal was injected i.p. with 0.15 ml of 5-bromo-2Ј-deoxyuridine (BRDU, 20 mg/ml) every 12 h for 4 successive days (i.e. 80 µmol BRDU total). The method of multiple injections of BRDU was a modification of the procedure reported recently by Ip et al. (11) . BRDU is incorporated into DNA during the S-phase of the cell cycle. Proliferative activity of mammary lobuloalveolar and ductal epithelial cells was determined by histochemical measurement of BRDU (12) . Hormones. On the fourth day after initiation of BRDU treatment, the animals were fasted overnight. Before termination by cervical dislocation, the animals were injected i.m. with an anesthetic cocktail containing ketamine (100 mg/ ml), xylazine (20 mg/ml) and acepromazine (10 mg/ml). Blood samples, always taken between 0700 and 1000 h, were drawn from the abdominal aorta, prepared for plasma and frozen (-20°C). Order of termination was Fig. 1 . LF, 5% (corn oil) w/w modified AIN-76A diet; HF, AIN-76A diet modified to contain 24.6% (corn oil) w/w fat. 1 Since there were no statistical differences between groups in mammary cell proliferation as a result of feeding regimen, non food-restricted and restricted food groups with the same intensity of restriction were combined for further statistical comparisons. ↑, Indicates food restriction by either 33% or 50%. During the 3 weeks of refeeding in each weight cycle, the restricted groups were fed daily the same volume of food as the non-restricted animals plus a fraction of the food that was withheld during restriction. *, Indicates weeks during which animals in each group underwent metabolic testing for 24 h. Order of metabolic testing of animals was randomized across treatment groups and days. T, Termination week (first refeed week of fifth weight cycle). BRDU (0.15 ml/animal) was administered i.p. every 12 h (twice daily) for 4 successive days (i.e. 80 µmol/animal). At termination, blood samples (fasted 14 h) were taken from abdominal aorta for measurement by radioimmunoassay of plasma concentrations of insulin, estrogen and progesterone. Corticosterone concentration in urine collected over 24 h was measured by radioimmunoassay.
counterbalanced across treatment groups. Concentration of insulin was measured by commercial radioimmunoassay ( 125 I Insulin RIA Kit, Linco Research Inc., St Louis, MO). Plasma estrogen was measured by radioimmunoassay using a modification of the original procedure of Korenman as described by Murray (13) ; plasma concentration of progesterone was measured by radioimmunoassay using a modification of the original procedure of Gibori (14) . Twenty-four hour corticosterone concentrations in urine were measured by radioimmunoassay according to the procedure published recently by Zhu et al. (15) .
A timeline summarizing the treatment groups and schedule of measurements is presented in Figure 1 . Experiment 2 Immunoprecipitation and immunoblotting of IRS-1. Frozen (-80°C) samples (150-200 mg wet weight) of confirmed mammary adenocarcinomas of Ad lib-C, ME-C and ME-WC 33 from the previous experiment (1) were selected randomly for measurement of tyrosine-phosphorylated IRS-1 levels. Tissue was pulverized and then homogenized on ice in 1.5 ml of Nonidet P-40 (NP-40) buffer (1% NP-40, 140 mM NaCl, 20 mM Tris-HCl, pH 7.5; 1 mM EDTA, 25 µg/ml leupeptin, 10 µg/ml aprotinin, 0.5 mM phenlymethlysulfonyl fluoride (PMSF) and 0.1 mM sodium orthovanadate). Protein concentrations were determined using the BCA Protein Assay (Pierce, Rockford, IL). Samples Multiple regression analysis: lobuloalveolar cells P ϭ 0.029; ductal cells P ϭ 0.06. Restriction treatment: 0, non-restricted controls (n ϭ 12); 33, WC animals (n ϭ 12) that were restricted by 33%; 50, WC animals (n ϭ 6) that were restricted by 50%. 33 (ad libitum-fed and 33% restricted); ME-C (non-restricted control fed two meals); ME-WC 33 (33% restricted and fed two meals); ME-WC 50 (50% restricted and fed two meals). Treatment effects analyzed by multiple regression: meal-eating vs ad libitum NS; weight cycling vs non-restricted P Ͻ 0.05.
were diluted with NP-40 buffer to normalize protein concentrations to 0.6 mg/ml. Homogenates were precleared by shaking with protein A-agarose beads (Pierce), agitated at 4°C for 20-30 min and centrifuged. Aliquots of precleared homogenates were added to IRS antibody (polyclonal rabbit, Upstate Biotechnology Inc., Lake Placid, NY) and incubated on ice. Fresh Protein A-agarose beads were added to each sample, which was then shaken, centrifuged and washed 5 times with NP-40/EDTA buffer. The samples were boiled in SDS buffer containing 5% mercaptoethanol, then centrifuged. Samples were loaded on SDS-polyacrylamide gels for resolution by electrophoresis according to procedure reported by Laemmli (16) using a 5% acrylamide lower gel. Samples were transferred to nitrocellulose in transfer buffer at 200 V for~12 h. For assessing levels of phosphorylation of IRS-1, an anti-phosphotyrosine monoclonal antibody (Upstate Biotechnology) was used as the primary antibody after multiple washes with PBS/Tween. Following incubation with primary antibody, the nitrocellulose membrane was washed and a secondary antibody (horseradish peroxidase conjugated sheep antimouse IgG) was added. The membrane was washed and tyrosine-phosphorylated IRS-1 was detected using Enhanced Chemiluminescence (ECL) (Pierce) on Hyperfilm-ECL (Kodak). Quantification of immunoblot density was measured by Arcus II transparency scanner (Agfa) and NIH Image 1.54 software for digitizing the image and quantifying its density in square pixels. Effects of weight cycling and feeding regimen on cell proliferation were a Efficiency of food utilization for growth (total weight gain/total food consumptionϫ100). During restriction (weeks 1, 5, 9, 13, 17), efficiency of food utilization among weight-cycled animals was less than for non-restricted controls (P Ͻ 0.0001); conversely, during weeks of refeeding (weeks 2-4, 6-8, 10-12, 14-16, 18), efficiency of food utilization among weight-cycled animals was greater than among non-restricted animals (P Ͻ 0.0001).
b All values are mean Ϯ SE. Cumulative food intake, body weight gain and efficiency of food intake for growth of non-restricted and weight-cycled groups.
Cumulative food consumed (P ϭ 0.01); body weight gain (NS) over 18 weeks. Effects of treatment analyzed by multiple regression. from non food-restricted animals (n ϭ 3) fed in two 3 h meals (ME-C); and from animals (n ϭ 4) that were food restricted by 33% for 1 week, then refed for 3 weeks over an 18 week period (ME-WC). For ME-WC, immunoblots in the first three lanes were used for statistical comparison because the blot in the fourth lane was not complete. Density of blots was quantified using digitized image analysis. Density values are expressed as mean Ϯ SE squared pixels. Diet effect on IRS-1 phosphorylation determined by ANOVA (P Ͻ 0.0001) and Tukey HSD for between group differences. ME-WCϾAd lib-C, P Ͻ 0.001; ME-CϾAd lib-C and ME-WCϾME-C, P Ͻ 0.01.
analyzed by multiple regression using the General linear model (Glm). Effects of weight cycling, substrate utilization, hormone concentration and the relationship between hormones and mammary lobuloalveolar cell proliferation were analyzed by multivariate or univariate regression analyses using the Glm. Tumor levels of tyrosine-phosphorylated IRS-1 were analyzed by analyses of variance and Tukey HSD for between group comparisons. All statistical analyses were performed using Systat for Windows: Statistics (version 5, 1992; Systat Inc., Evanston, IL) (17) . Statistical significance of each analysis is reported in the text and in relevant figures. All experimental methods and procedures were approved by the University's Animal Care and Use Committee.
Results
Analysis of variance of mammary epithelial cell proliferation in response to ad libitum versus meal eating and food restriction versus no restriction, indicated that only weight cycling had a significant effect on cell proliferation (P Ͻ 0.05) (Table I) . Therefore, groups that were not food restricted (i.e. Ad lib-C and ME-C) and weight-cycled groups (Ad lib-WC 33 and ME-WC 33 ) were combined (as indicated in Figure 1 ) for all further statistical comparisons. Upon further analysis, weight cycling was found to increase mammary lobuloalveolar cell proliferation in a linear fashion (P ϭ 0.029). Proliferation of mammary ductal epithelial cells showed a similar trend that approached statistical significance (P ϭ 0.06) (Figure 2 ). There were no differences in estrous cyclicity among groups during restriction or refeeding weeks. The mean (Ϯ SD) length of an estrous cycle among non-restricted and weight-cycled animals was 4.3 Ϯ 0.6) and 4.5 Ϯ 0.6 days respectively.
Weight-cycled groups consumed 6-10% less total food than the non-restricted groups (P ϭ 0.01). During food restriction, efficiency of food utilization for growth among the weightcycled animals was lower than for non-restricted animals (P Ͻ 0.0001). On the other hand, efficiency of food utilization during weeks of refeeding from food restriction was~71-89% greater than controls (P Ͻ 0.0001). Hence, there was no difference in body weight gain or final body weights between non-restricted and weight-cycled groups (Table II) .
During weeks of food restriction, energy expenditure (P ϭ 0.005), glucose (P Ͻ 0.0001), and protein (P ϭ 0.006) utilization of the weight-cycled animals were significantly less than the non-restricted control animals ( Figure 3 ). There were no differences in lipid utilization. During weeks of recovery from food restriction, weight-cycled animals used less lipid for energy (P ϭ 0.05) than the non-restricted controls. There were no differences in energy, glucose or protein utilization between groups. High within-group variability precluded our detecting any statistical differences in plasma insulin, estrogen, progesterone, or urinary corticosterone between weight-cycled and non food-restricted animals. From inspection, the plasma insulin, and to a lesser extent, estrogen and progesterone, varied non linearly in response to weight cycling (Figure 4) . In an initial attempt to determine whether the effects of weight cycling on mammary lobuloalveolar cell proliferation were related to variations in hormone levels, univariate regression analyses were performed using both a linear and squared expression of each hormone as the independent variables and mammary lobuloalveolar cell proliferation as the dependent variable. Insulin and estrogen, separately, were both linearly and quadratically related to mammary cell proliferation (P Ͻ 0.01); insulin: r ϭ 0.71, r 2 ϭ 0.5; estrogen: r ϭ 0.55, r 2 ϭ 0.3. There was no relationship between either progesterone or corticosterone and mammary cell growth. When the linear and quadratic components of all four hormones were entered together as independent variables in a multivariate regression model, the model had a multiple r ϭ 0.947 and an r 2 ϭ 0.897 (P ϭ 0.003), and insulin (both linear and quadratic components) was the only significant predictor (P ഛ 0.01) of mammary lobuloalveolar cell proliferation.
In mammary tumors of weight-cycled animals (Experiment 2), phosphotyrosine activation of IRS-1 was five times greater than that of ad libitum-fed, non-restricted animals (P Ͻ 0.0001) and almost 3-fold greater than meal-fed, non-restricted animals (P Ͻ 0.01). Phosphorylation of IRS-1 ( Figure 5 ) in mammary tumors of meal-fed controls also was greater than ad libitumfed controls (P Ͻ 0.01).
Discussion
Energy intake has been found to be a sensitive modulator of mammary carcinogenesis in laboratory animals (18) (19) (20) (21) (22) . A 12% restriction in dietary energy was found to reduce both incidence and development of mammary cancer in rats pretreated with 7,12-dimethylbenz[a]anthracene (DMBA) (23) . Furthermore, a 14-25% restriction of dietary energy of young virgin female mice dramatically reduced mammary lobuloalveolar and ductal cell proliferation (24) . The inhibitory action of energy restriction on mammary cell proliferation and tumorigenesis has been reported to be effected at least in part by the suppression of insulin (6, 25) and estrogen (26) . Engleman et al. (27) have shown that caloric restriction suppresses local growth stimuli, such as epidermal growth factor (EGF). In addition, the positive status of corticosterone, through mechanisms that are less apparent, is necessary for inhibition of tumorigenesis by chronic caloric restriction (28).
Recently, we reported female rats (weight cycled for 18 weeks) decreased total food intake by 14% but increased the incidence of MNU-induced mammary cancer in comparison to ad libitum-fed controls. Furthermore, tumors of the weightcycled animals were heavier (P ϭ 0.09) and tumor number was similar between groups (1). The present investigation was a follow-up to that experiment. Weight-cycled animals that were food restricted by 33% and 50% consumed significantly less food (6-10%) than the non-restricted controls. However, rate of mammary lobuloalveolar cell proliferation among weight-cycled animals was 33-55% greater than the controls. Although weight-cycled animals consumed less food than the controls, the former had a 71-89% greater efficiency of food utilization for growth during recovery weeks that resulted in a total body weight gain that was similar to the non-restricted controls. Only plasma insulin was a significant predictor of mammary lobuloalveolar cell proliferation. Although univariate regression analysis indicated that plasma estrogen also was highly related to mammary lobuloalveolar cell growth, it was not found to be significant when it was included with insulin, progesterone, and urinary corticosterone in a multivariate regression model that explained 90% of the variation in mammary cell growth. This finding indicated that the effects of estrogen on mammary cell growth were not independent of insulin. Insulin has been reported to increase estrogen binding to mammary cells (4) . Hence, we suspect that most of the hormonal effects on mammary cell proliferation may have been the result of mitogenic stimulation by insulin and its secondary effects via an enhancement of estrogen binding.
Cell proliferation is a high risk condition for genomic insult by a carcinogen and/or the promotion of a neoplastic growth (28, 29) . In the present study, weight cycling stimulated mammary lobuloalveolar cell proliferation which could be explained, to a great extent, by plasma insulin. Insulin-like growth factor 1 (IGF-1) also has been reported to be a promoter of mammary cell proliferation (31) . Since IGF-1 was not measured, we cannot rule out its involvement in the effects reported here. Stimulation of DNA synthesis and cell proliferation by insulin require tyrosine phosphorylation of IRS-1 which is dependent on direct stimulation by either insulin and/or IGF-1 and their respective membrane receptors (32) . Tyrosine phosphorylation of IRS-1 in mammary tumors of weightcycled rats, in the present study, was several fold greater than non-restricted controls.
The link between breast cancer and insulin is not new. Earlier reports have shown that normal insulin secretion was required for development of mammary cancer in rats pretreated with DMBA (5,33) and promoted breast cancer in genetically obese, hyperinsulinemic LN/A-cp rats in comparison to their lean littermates (6) . Examination of glucose oxidation in vitro, showed that the dependency of mammary tumor cell proliferation on insulin was not related to glucose metabolism, which indicated indirectly, that the primary cellular pathway of insulin action was on mitogenesis (33) . On the other hand, chronic caloric restriction has been shown to suppress plasma insulin (34) and IGF-1 levels (34) and DMBA-induced cancer in rats. There is growing speculation that insulin may be an important etiological factor in both human breast and colon cancers (35) (36) (37) .
To our knowledge, the evidence of weight cycling, mammary epithelial cell proliferation, and their relationship to insulin stimulation has not been reported. We hypothesize that weight cycling may increase the development of a subpopulation of cancer in breast as well as other metabolically active tissues that are exposed to frequent or chronic insulin stimulation. Since weight cycling is a common method of weight control among women, further study of this dietary practice and insulin stimulation on regulatory mechanisms of mammary cell proliferation and tumor development warrant further investigation.
